News – Division of Gastroenterology and Hepatology-CUHK

News & Events

CUHK study finds vigorous disinfection linked to increased risk of eczema and atopic diseases

3 Feb 2025

CUHK study shows short-chain fatty acids produced by probiotic bacteria in the gut can boost immunity against influenza and other viral infections

15 Jan 2025

CU Medicine develops the Metagenome-Assembled Genome Inventory for Children (MAGIC) to promote early-life microbiome research

30 Dec 2024

CU Medicine invents a non-invasive technology for people with uninvestigated bowel symptoms

4 Dec 2024

8 Division of Gastroenterology and Hepatology Professors Named Highly Cited Researchers 2024

21 Nov 2024

CU Medicine’s large-scale mother-baby study finds altered gut microbiome in pregnant mothers with gestational diabetes mellitus affects infants’ neurodevelopment

21 Aug 2024

CUHK identifies novel gut microbiome biomarkers to facilitate diagnosis of autism spectrum disorders Pilot clinical study shows modulation of gut microbiome alleviates anxiety symptoms

11 July 2024

CUHK study reveals microbiota modulation is effective in alleviating insomnia

27 June 2024

CUHK Professor Siew Ng is the first female clinician-scientist in mainland China selected as a New Cornerstone Investigator; New Cornerstone Science Laboratory inaugurated to dissect diet-microbiome interactions to improve human health

10 June 2024

CUHK study reveals antiviral drug tenofovir disoproxil fumarate increases fracture risk in elderly patients with chronic hepatitis B

21 Mar 2024

CUHK identifies Streptococcus anginosus as a pathogen that promotes gastric tumour formation

13 Mar 2024

CU Medicine proves AI-assisted colonoscopy increases adenoma detection rate by 40%, and trains a new AI platform to assist early-stage gastrointestinal cancer treatment

26 Dec 2023

CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms

8 Dec 2023

CU Medicine establishes an internationally accredited biobank: A prerequisite for Hong Kong to be the hub for new drug development in the Greater Bay Area

10 July 2023

A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

22 May 2023

CU Medicine leads new clinical practice guidelines on use of non-invasive biomarkers for colorectal cancer screening with international experts

10 May 2023

CU Medicine’s population-based long COVID-19 survey estimates that over 400,000 recovered COVID-19 patients suffer from sexual dysfunction and reproductive problems

20 April 2023

CUHK study reveals risk of liver-related complications but not liver cancer decreases over time in patients who have recovered from hepatitis B
Regular cancer surveillance is recommended

30 Mar 2023

CU Medicine, MagIC and HKSTP join hands to organise the Microbiome Summit 2023 ‘Hong Kong as a regional hub for microbiome industry’

13 Jan 2023